{"id":"https://openalex.org/W4379984757","doi":"https://doi.org/10.1158/1538-7445.am2023-6481","title":"Abstract 6481: Systematic review of the literature: tertiary prevention in leukemia patients","display_name":"Abstract 6481: Systematic review of the literature: tertiary prevention in leukemia patients","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4379984757","doi":"https://doi.org/10.1158/1538-7445.am2023-6481"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-6481","doi":"https://doi.org/10.1158/1538-7445.am2023-6481","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-6481","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5092123047","display_name":"Nikita Manyak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikita Manyak","raw_affiliation_strings":["1UCLA - University of California Los Angeles, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA - University of California Los Angeles, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012046553","display_name":"Su Yon Jung","orcid":"https://orcid.org/0000-0002-0513-1830","observed_orcids":["https://orcid.org/0000-0002-0513-1830"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Su Yon Jung","raw_affiliation_strings":["1UCLA - University of California Los Angeles, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA - University of California Los Angeles, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"6481","last_page":"6481"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tertiary-prevention","display_name":"tertiary prevention","score":0.878000020980835},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.9380000233650208},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7820000052452087},{"id":"https://openalex.org/keywords/pediatric-leukemia","display_name":"pediatric leukemia","score":0.7009999752044678},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.777999997138977},{"id":"https://openalex.org/keywords/blinatumomab","display_name":"blinatumomab","score":0.8080000281333923},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.5429999828338623},{"id":"https://openalex.org/keywords/cranial-irradiation","display_name":"cranial irradiation","score":0.8349999785423279},{"id":"https://openalex.org/keywords/allogeneic-stem-cell-transplantation","display_name":"allogeneic stem cell transplantation","score":0.984000027179718},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9319999814033508},{"id":"https://openalex.org/keywords/tisagenlecleucel","display_name":"tisagenlecleucel","score":0.9549999833106995},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.5},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6309999823570251},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.4950000047683716},{"id":"https://openalex.org/keywords/daunorubicin","display_name":"daunorubicin","score":0.7459999918937683},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9789999723434448}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8427742123603821},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5307790040969849},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49598559737205505},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.48327046632766724},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.47693508863449097},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.45514941215515137},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.425438791513443},{"id":"https://openalex.org/C189708586","wikidata":"https://www.wikidata.org/wiki/Q1504425","display_name":"Systematic review","level":3,"score":0.41919466853141785},{"id":"https://openalex.org/C2778020697","wikidata":"https://www.wikidata.org/wiki/Q410189","display_name":"Blinatumomab","level":4,"score":0.4162288308143616},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.375668466091156},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3262125551700592},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.19993102550506592},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-6481","doi":"https://doi.org/10.1158/1538-7445.am2023-6481","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-6481","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4400906007","https://openalex.org/W2408626422","https://openalex.org/W2053758140","https://openalex.org/W1985214589","https://openalex.org/W2163316004","https://openalex.org/W2409494181","https://openalex.org/W1993927318","https://openalex.org/W2404609518","https://openalex.org/W7098279769","https://openalex.org/W2031201988"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"After":[2],"conducting":[3],"a":[4,9,241,288,297,343,389,424],"thorough":[5],"search,":[6],"we":[7,78,93],"found":[8,80,215],"lack":[10],"of":[11,19,91,103,132,150,233,257,291,299,437,448],"published":[12,82],"literature":[13,41],"review":[14,42,436],"about":[15,25],"the":[16,34,44,60,69,75,85,89,178,221,246,253,264,283,300,311,319,381,403,412,438,449],"tertiary":[17,364,425,440],"prevention":[18,426,441],"patients":[20,167,176,191,209,238,258,301,444],"with":[21,129,168,193,196,198,263,287,417],"leukemias":[22,116,356],"and":[23,37,57,67,97,120,134,144,152,214,228,305,328,335,395,461],"discussion":[24],"their":[26],"prognosis.":[27],"We":[28,47],"thus":[29],"searched":[30],"related":[31,86],"publications":[32],"in":[33,117,190,220,224,314,393,442],"last":[35,76],"decade":[36,390],"wrote":[38],"an":[39,49],"extensive":[40,50],"on":[43,84,414,423],"topic.":[45,87],"Method:":[46],"conducted":[48],"search":[51,70],"for":[52,74,101,115,166,175,208,391,411,452],"electronic":[53],"database":[54],"via":[55],"MEDLINE":[56],"PubMed.":[58],"Using":[59],"key":[61],"terms":[62],"\u201cprogression-free":[63],"survival":[64,154,163,185,254,270,371],"(PFS)":[65],"leukemia\u201d":[66],"restricting":[68],"to":[71,125,156,216,230,245,252,308,353,401],"\u201cEnglish":[72],"language\u201d":[73],"decade,":[77],"initially":[79],"1,083":[81],"papers":[83],"On":[88],"basis":[90],"review,":[92],"collected":[94],"necessary":[95],"data":[96],"extracted":[98],"some":[99,323],"recommendations":[100],"treatment":[102,247,286,375],"leukemia":[104,392,443],"patients.":[105],"Results:":[106],"Standard":[107],"treatments":[108,200,383],"such":[109],"as":[110],"Daunorubicin,":[111],"Doxorubicin,":[112],"or":[113,363,368],"Asparaginase":[114],"children,":[118],"adolescents,":[119,396],"young":[121],"adults":[122],"(ages":[123],"18":[124],"24)":[126],"were":[127,260,306],"associated":[128],"high":[130],"rates":[131,149,232,271],"relapse":[133,227],"other":[135,157,199],"complications":[136],"within":[137],"5":[138,367],"years":[139],"post-treatment.":[140],"Of":[141,316],"note,":[142,317],"Blinatumomab":[143],"Ibrutinib-Rituximab":[145],"showed":[146],"higher":[147,231,268,289],"success":[148],"PFS":[151],"overall":[153,184,234],"compared":[155,195,251],"chemotherapy":[158,170,194],"treatments.":[159,339],"Two-year":[160],"disease":[161],"free":[162],"was":[164,173,186,376],"39.0%":[165],"intensive":[169],"while":[171],"it":[172],"54.4%":[174],"given":[177],"anticancer":[179],"drugs.":[180],"In":[181,202,340],"addition,":[182],"two-year":[183],"relatively":[187],"worse":[188],"(58.4%)":[189],"treated":[192,262],"those":[197],"(71.3%).":[201],"comparison,":[203],"radiotherapy":[204],"has":[205,350],"been":[206,282,326,351,386],"used":[207],"who":[210,259],"relapsed":[211,302,360],"after":[212,294,304,361,373,406],"remission":[213],"be":[217,402],"more":[218,330],"successful":[219],"long":[222],"run":[223],"preventing":[225],"another":[226],"leading":[229],"survival.":[235],"For":[236,273],"example,":[237],"previously":[239],"experienced":[240,267],"78%":[242],"response":[243],"rate":[244,255,290,372],"received":[248],"cranial":[249],"radiation;":[250],"(11.3%)":[256],"not":[261],"radiation,":[265],"they":[266,358],"four-year":[269],"(77.7%).":[272],"most":[274,284,404],"pediatric":[275,355],"leukemias,":[276],"allogenic":[277],"stem":[278,337],"cell":[279,338],"therapies":[280],"have":[281,325,359,385],"effective":[285,331,405],"remission.":[292,365],"However,":[293],"this":[295,374],"treatment,":[296],"majority":[298],"soon":[303],"unable":[307],"continue":[309],"fighting":[310],"disease,":[312],"resulting":[313],"death.":[315],"during":[318,388],"past":[320],"10":[321,369],"years,":[322],"immunotherapies":[324,413],"discovered":[327],"reported":[329],"than":[332],"traditional":[333],"chemo/radiotherapies":[334],"allogenic/autologous":[336],"particular,":[341],"Tisagenlecleucel,":[342],"chimeric":[344],"antigen":[345],"receptor":[346],"(CAR)":[347],"T-cell":[348,398],"therapy,":[349],"approved":[352],"treat":[354],"when":[357],"initial":[362],"Their":[366],"year":[370],"over":[377],"50%.":[378],"Conclusion:":[379],"Among":[380],"standard":[382],"that":[384],"studied":[387],"children":[394],"CAR":[397],"immunotherapy":[399],"appears":[400],"patient":[407],"relapse.":[408],"More":[409],"research":[410],"different":[415],"populations":[416],"diverse":[418],"age":[419],"groups":[420],"is":[421],"requested":[422],"perspective.":[427],"Citation":[428],"Format:":[429],"Nikita":[430],"Manyak,":[431],"Su":[432],"Yon":[433],"Jung.":[434],"Systematic":[435],"literature:":[439],"[abstract].":[445],"In:":[446],"Proceedings":[447],"American":[450],"Association":[451],"Cancer":[453,472],"Research":[454],"Annual":[455],"Meeting":[456],"2023;":[457],"Part":[458],"1":[459],"(Regular":[460],"Invited":[462],"Abstracts);":[463],"2023":[464],"Apr":[465],"14-19;":[466],"Orlando,":[467],"FL.":[468],"Philadelphia":[469],"(PA):":[470],"AACR;":[471],"Res":[473],"2023;83(7_Suppl):Abstract":[474],"nr":[475],"6481.":[476]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2023-06-10T00:00:00"}